The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C

Gastroenterology

Volumn 116, Issue 1, 1999, Pages 127-134

  Kazemi Shirazi, L ^a   Datz, C ^a   Maier Dobersberger, T ^a   Kaserer, K ^a   Hackl, F ^a   Polli, C ^a   Steindl, P E ^a   Penner, E ^a   Ferenci, P ^a  

^a Gastroenterology and Hepatology   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; DNA; IRON; VIRUS RNA;

ADULT; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; HEMOCHROMATOSIS; HEPATITIS C; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; IRON OVERLOAD; LIVER BIOPSY; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0032947967     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70236-2     Document Type: Article

References (55)

1. AM DiBisceglie CA Axiotis JH Hoofnagle BR. Bacon Measurements of iron status in patients with chronic hepatitis Gastroenterology 102 1992 2108 2113
2. N Arber FM Konikoff M Moshkowitz M Baratz A Hallak M Santo Z Halpern H Weiss T. Gilat Increased serum iron and iron saturation without liver iron accumulation distinguish chronic hepatitis C from other chronic liver diseases Dig Dis Sci 39 1994 2656 2659
3. RF Farinati R Cardin N DeMaria GD Lebera C Marafin E Lecis P Burra A Floreani A Cecchetto R. Naccarato Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis J Hepatol 22 1995 449 456
4. A Piperno R D'Alba S Fargion L Roffi M Sampietro S Parma V Arosio M Fare G. Fiorelli Liver iron concentration in chronic viral hepatitis: a study of 98 patients Eur J Gastroenterol Hepatol 7 1995 1203 1208
5. O Riggio F Montagnese P Fiore S Folino S Giambatolomei C Gandin M Merli I Quinti N Violante S Caroli O Serofonte L. Capocaccia Iron overload in patients with chronic viral hepatitis: how common is it? Am J Gastroenterol 92 1997 1298 1301
6. HL Bonkowsky BF Banner AL. Rothman Iron and chronic viral hepatitis Hepatology 25 1997 759 768
7. A Piperno S Fargion R D'Alba L Roffi AL Fracanzani L Vecchi M Failla G. Fiorelli Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infections J Hepatol 16 1992 364 368
8. F Farinati R Cardin A D'Erricon N De Maria R Naccarato A Cecchetto W. Grigioni Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation Hepatology 23 1996 1468 1475
9. NK Beinker MD Voigt M Arendse J Smit IA Stander RE. Kirsh Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C J Hepatol 25 1996 633 638
10. DH Van Thiel L Friedlander S Fagiuoli H Wright W Irish JS. Gavaler Response to interferon alpha therapy is influenced by the iron content of the liver J Hepatol 20 1994 410 415
11. JK Olynyk KR Reddy AM Di Bisceglie LJ Jeffers TI Parker JL Radick ER Schiff BR. Bacon Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic HCV Gastroenterology 108 1995 1104 1109
12. Y Ikura H Morimot H Johmura M Fukui M. Sakurai Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C Am J Gastroenterol 91 1996 1367 1373
13. S Fargion Al Fracanzani M Sampietro V Molteni R Boldorini M Mattioli B Cesana G Lunghi A Piperno C Valsecchi G. Fiorelli Liver iron influences the response to interferon alpha therapy in chronic hepatitis C Eur J Gastroenterol Hepatol 9 1997 497 503
14. A Piperno M Sampietro R D'Alba L Roffi S Fargion S Parma C Nicoli N Corbetta M Pozzi V Arosio G Boari G. Fiorelli Iron stores, response to alpha interferon therapy, and effects of iron depletion in chronic hepatitis C Liver 16 1996 248 254
15. HL. Bonkovsky Therapy of hepatitis C: other options Hepatology 26 1997 143S 151S
16. K Kaserer R Fiedler P Steindl Ch Müller F Wrba P. Ferenci Liver biopsy is a useful predictor of response to interferon-therapy in chronic hepatitis C Histopathology 32 1998 454 461
17. NC Tsai E Zuckerman SH Han K Goad AC Redeker TL. Fong Effect of iron depletion on long term response to interferon-alpha therapy in patients with chronic hepatitis C who previously did not respond to interferon therapy Am J Gastroenterol 92 1997 1831 1834
18. H Hayashi T Takikawa N Nishimura M. Yano Serum aminotransferase levels as an indicator of the effectiveness of venesection for chronic hepatitis C J Hepatol 22 1995 268 271
19. Y Deugnier D Battistelli H Jouanolle D Guyader M Gueguen O Loreal C Jacquelinet M Bourel P. Brissot Hepatitis B virus infection markers in genetic hemochromatosis. A study of 272 patients J Hepatol 13 1991 286 290
20. ED Lustbladder HL Hann BS. Blumberg Serum ferritin as a predictor of host response to hepatitis B virus infection Science 220 1983 423 425
21. BR Bacon MW Fried AM. DiBisceglie A 39 year old man with chronic hepatitis, elevated serum ferritin values, and a family history of hemochromatosis Semin Liver Dis 13 1993 101 105
22. JN Feder A Gnirke W Thomas Z Tsuchihashi DA Ruddy A Basava F Dormishian R Domingo Jr MC Ellis A Fullan LM Himton NL Jones BE Kimmel GS Kronmal P Lauer VK Lee DB Loeb FA Mapa E McClelland NC Meyer GA Mintier N Moeller T Moore E Morikang CE Prass L Quintana SM Starnes RC Schatzman KJ Brunke DT Drayna NJ Risch BR Bacon RK. Wolff A novel MHC class I–like gene is mutated in patients with hereditary hemochromatosis Nat Genet 13 1996 399 408
23. A Piperno R D'Alba L Roffi M Pozzi A Farina L Vecchi G. Fiorelli Hepatitis C virus infection in patients with idiopathic hemochromatosis (IH) and porphyria cutanea tarda Arch Virol 4 suppl 1992 215 216
24. AM Jouanolle G Gandon P Jezequel M Blayau ML Campion J Yaouanq GM. Brittenham Hemochromatosis and HLA-H Nat Genet 14 1996 251 252
25. UH. Consortium A simple genetic test identifies 90% of UK patients with hemochromatosis Gut 41 1997 841 844
26. EC Jazwinska LM Cullen F Busfield WR Pyper SI Webb LW Powell CP Morris TP. Walsh Hemochromatosis and HLA-H Nat Genet 14 1996 249 251
27. Ch Datz MRA Lalloz W Vogel I Graziadei F Hackl G Vautier DM Layton TH Maier-Dobersberger P Ferenci E Penner F Sandhofer A Bomford B. Paulweber Predominance of the HLA-H gene G845A mutation in Austrian patients with genetic hemochromatosis J Hepatol 27 1997 773 779
28. A Piperno M Sampietro A Pietrangelo C Arosio L Lupica G Montosi A Vergani M Fraquelli D Girelli P Pasquero A Roetto P Gasparini S Fargion D Conte C. Camaschella Heterogeneity of hemochromatosis in Italy Gastroenterology 114 1998 996 1002
29. E. Beutler Genetic irony beyond hemochromatosis: clinical effects of HLA-H mutations Lancet 349 1997 296 297
30. C Oesterreicher J Hammer U Koch F Pfeffel G Sunder-Plassmann D Peterman Ch Müller HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis Kidney Int 48 1995 1967 1971
31. P Simmonds A Alberti HJ Alter F Bonino DW Bradley C Brechot JT Brouwer SW Chan K Chayama DS. Chen A proposed system for the nomenclature of hepatitis C virus genotypes Hepatology 19 1994 1321 1324
32. PJ. Scheuer Classification of chronic viral hepatitis: a need for reassessment J Hepatol 13 1991 372 373
33. JW Rowe JR Wands E Mezey E Waterbury JR Wright J Tobin R. Anders Familial hemochromatosis: characteristics of the precirrhotic stage in precirrhotic stage in a large kindred Medicine (Baltimore) 56 1977 197 211
34. JW Searle JFR Kerr JW Halliday LW. Powell Iron storage disease 2nd ed RNM McSween PP Anthony PJ Scheuer Pathology of the liver. 1989 : Churchill Livingstone New York 181 201
35. KM Summers JW Halliday LW. Powell Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index Hepatology 12 1990 20 25
36. BR. Bacon Diagnosis and management of hemochromatosis Gastroenterology 113 1997 995 999
37. SG Gehrke D Riedel BA Fitscher T Goeser W Stremmel B. Kallinowski Prevalence of mutations in the hemochromatosis gene HLA-H in patients with chronic hepatitis C: influence on histological activity, iron metabolism, and response to interferon therapy (abstr) Hepatology 26 1997 410A
38. C Hezode C Cazeneuve O Coue' JM Pawlotsky ES Zafrani S Amselem D. Dhumeaux Hemochromatosis C282Y mutation and liver iron overload in patients with chronic active hepatitis C Hepatology 27 1998 306
39. BC Smith J Grove MA Guzail CP Day AK Daly AD Burt MF. Bassendine Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C Hepatology 27 1998 1695 1699
40. M Sampietro A Piperno L Lupica C Arosio A Vergani N Corbetta I Malosio M Mattioli AL Francanzani MD Cappellini G Fiorelli S. Fargion High prevalence of the H63D HFE mutation in Italian patients with porphyria cutanea tarda Hepatology 27 1998 181 184
41. A Piperno A Vergani C Arosio I Malosio S Parma C Nicoli A Ricci V Arosio L Roffi G Bovo G. Mancia Iron overload in patients with chronic viral hepatitis: role of the HLA-H gene (abstr) J Hepatol 26 suppl 1 1997 85
42. ALC Martinelli RF Franco MG Villanova AB Arau'jo Filho JFC Figueiredo DT Covas ADC Passos M Secaf SS Rodrigues M Tavella S Zucoloto MA. Zago Hemochromatosis C282Y and H63D mutations in hepatitis C virus infection: correlation with ALT and iron serum levels (abstr) J Hepatol 28 suppl 1 1998 55
43. NJ Shaheen BR Bacon IS. Grimm Clinical characteristics of hereditary hemochromatosis patients who lack the C282Y mutation Hepatology 28 1998 526 529
44. PC. Adams Iron overload in viral and alcoholic liver disease J Hepatol 28 suppl 1 1998 19 20
45. DK George S Goldwurm GA Macdonald LL Cowley NI Walker PJ Ward EC Jazwinska LW. Powell Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis Gastroenterology 114 1998 311 318
46. A. Pietrangelo Iron, oxidative stress and liver fibrogenesis J Hepatol 28 suppl 1 1998 8 13
47. T Poynard P Bedossa P. Opolon Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups Lancet 349 1997 825 832
48. ZJ Bulaj LM Griffen LB Jorde CQ Edwards JP. Kushner Clinical and biochemical abnormalities in people heterozygous for hemochromatosis N Engl J Med 335 1996 1799 1805
49. AG Roberts SD Whatles RR Morgan M Worwood GH. Elder Increased frequency of the hemochromatosis C282Y mutation in sporadic porphyria cutanea tarda Lancet 349 1997 321 323
50. PC Adams S. Chakrabarti Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria Gastroenterology 114 1998 319 323
51. DA Rhodes R Raha Chowdhury TM Cox J. Trowsdale Homozygosity for the predominant C282Y mutation and absence of disease expression in hereditary haemochromatosis J Med Genet 34 1997 761 764
52. RL Sham CY Ou J Cappuccio C Braggins K Dunnigan PD. Phatak Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases Blood Cells Mol Dis 23 1997 314 320
53. M de Sousa G. Porto The immunological system in hemochromatosis J Hepatol 28 suppl 1 1998 1 7
54. RD Klausner TA Rouault JB. Harford Regulating the fate of mRNA: the control of cellular iron Cell 72 1993 19 28
55. MW Hentze LC. Kuhn Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress Proc Natl Acad Sci USA 93 1996 8175 8182